DV Trading’s Soleno Therapeutics SLNO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-54,000
Closed -$1.81M 677
2026
Q1
$1.81M Hold
54,000
0.04% 120
2025
Q4
$2.5M Buy
+54,000
New +$2.96M 0.07% 68

DV Trading's SLNO Position: Q2 2026 in Review

DV Trading sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 54,000 shares — an estimated $1.81M sold.

DV Trading first reported a position in SLNO in Q4 2025 and held it in 2 quarters. The position peaked at $2.5M in Q4 2025. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

  • DV Trading reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
  • DV Trading sold 54,000 Soleno Therapeutics shares in Q2 2026, an estimated $1.81M.
  • DV Trading first reported a position in Soleno Therapeutics in Q4 2025 and held it in 2 quarters.
  • DV Trading's Soleno Therapeutics position peaked at $2.5M in Q4 2025.
  • 0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on DV Trading's 13F filing for Q2 2026, filed 14 Aug 2026.